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In a blind test of protein-docking algorithms, six 
groups used different methods to predict the 
structure of a protein complex. All six predicted 
structures were close enough to the experimental 
complex to be useful; nevertheless, several important 
details of the experimental complex were missed or 
only partially predicted. 
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Interactions between macromolecules are at the heart of 
biological activity and specificity, and are vital for signal 
transduction, cell-cycle control, the regulation of transcrip- 
tion and translation, DNA repair, and many other 
processes. The question of how molecules such as pro- 
teins recognize each other has consequently received 
much attention. 
The physical bases for the interactions between proteins 
have been understood for some time. In 1940, Linus 
Pauling [l] attributed the association of biological macro- 
molecules to forces including: 
van der Waals attraction and repulsion, electrostatic 
interactions, hydrogen-bond formation etc., which are 
now rather well understood. These interactions are 
such as to give stability to a system of two molecules 
with complementary structures in juxtaposition... A 
general argument regarding complementariness may 
be given. Attractive forces between molecules vary 
inversely with a power of distance, and maximum sta- 
bility of a complex is achieved by bringing molecules 
as close together as possible, in such a way that posi- 
tively charged groups are brought near to negatively 
charged groups, electric dipoles are brought into suit- 
able mutual orientations, etc... (In) order to achieve 
maximum stability, the two molecules must have 
complementary surfaces, like die and coin, and also a 
complementary distribution of active groups. 
Since Pauling’s time, structural biologists have tried to 
apply the physical chemistry of molecular interactions to 
predict exactly how these complementary surfaces might 
come together, with mixed results. 
What has come to be called the ‘protein docking problem’ 
[Z] has its origins in the large size and complex shape of 
protein molecules. Everyone came to agree with Pauling 
that stable complexes were formed when molecules could 
match complementary functionalities. What remained dif- 
ficult was identifying exactly which of the many ‘knobs 
and holes’ [3] present on the surface of a protein should 
be fit together. Often, more than one fit seemed possible. 
Distinguishing among the different possible fits required 
the proper evaluation of their interaction energies. 
Quantum mechanical evaluation, although well devel- 
oped for small molecules, was not feasible for proteins - 
simpler methods for calculating interaction energies were 
required. These methods had to consider the possibility 
of cooperative effects on binding. Such effects included 
changes in the conformation of the interacting molecules 
and changes in their potential surfaces. These cooperative 
effects made the problem of distinguishing among the 
different possible fits especially difficult. 
How to tell right from wrong 
The effect of these uncertainties has been evident since 
the first protein docking simulations were conducted in 
the late 1970s. In a seminal paper published in 1978, 
Wodak and Janin showed that with modern computers, 
simplified force-fields and simplified protein representa- 
tions, they could fit two proteins together, regenerating 
the experimental configuration of the complex [4]. But 
their simulation also fit the proteins together in ways that 
differed from the X-ray crystal structure. Originally, it was 
believed that these non-native configurations would be 
excluded by using functional criteria, better representa- 
tions of the protein and more sophisticated force-fields [S]. 
The problem has turned out to be more difficult to solve 
than was anticipated; despite the use of increasingly 
complex energy schemes and protein representations 
[6-151, the problem of multiple solutions continued to 
arise. The problem was especially acute when the confor- 
mations used in docking calculations were from proteins 
crystallized without their partner (for an example, see 
Fig. 1) [6,7]. Determining which of the several calculated 
complexes is likely to correspond to the experimentally 
determined complex, and accounting for conformational 
change on binding, are still considered major challenges. 
Testing our assumptions 
A recent paper [16] gives grounds for renewed, but cau- 
tious, optimism. The crystallography group of Strynadka 
and James challenged investigators who had developed 
docking software to predict the structure of a complex 
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Figure 1 
Two dockings of BRTI (green) with trypsin (red) [6]. (a) A configuration 
0.52 A  from the experimental structure. (b) A configuration 21.41 A  
from the experimental structure. Both complexes have large, 
complementary interfaces that are difficult to distinguish between by 
several different measurements of complementarity. 
before it was solved. The dockers were given the crystal 
structures of the two proteins, the p-lactamase TEM-1 (263 
amino acids) and the B-lactamase inhibitor protein (BLIP; 
165 amino acids), in their uncomplexed forms. TEM-1 had 
been well studied, but BLIP was a new protein about 
which little was known except for its three-dimensional 
structure and the fact that it binds tightly to TEM-1. The 
residues involved in the interface between TEM-1 and 
BLIP were unknown, nor was it known whether the 
conformations of the molecules changed on binding. 
Each of the six groups who accepted the crystallogra- 
phers’ challenge was able to predict the structure of the 
complex [16] (Table 1). Five of these groups used funda- 
mentally different algorithms to generate the predicted 
complexes [6-9,171, and each group used different energy 
evaluation schemes to judge among the different possibil- 
ities calculated [6-9,17-211. (For an excellent discussion 
of some of the technical aspects of the docking calcula- 
tions performed by the six groups, see [ZZ].) Five of the 
six groups submitted more than one prediction. Four of 
these five picked as their most likely prediction the one 
that turned out to resemble the experimental structure 
most closely. A fifth group did not rank their structures. 
The sixth group submitted one structure only; it closely 
resembled the experimental structure (Table 1). Visual 
comparison of the predicted and experimental structures 
showed a high degree of similarity (Fig. 2). The predic- 
tions were judged to have been good enough to have 
helped solve the experimental structure using molecular 
replacement techniques [ 161. The similarities between 
the predicted and experimental structures, and the wide 
range of docking methods used to generate them, suggest 
Table 1 
Comparison of the computer-docked complexes to the X-ray 
crystal structure Cl61. 
Group RMS of best Rank of best Number of 
prediction (& predictionb predictions 
Eisenstein 1.10 1 3 
&  Katchalski-Katzir 
Shoichet 
&  Kuntz 
1.60 1 15 
Jackson 
&  SternbergC 
Abagayan 
&  Totrov 
1.09 1 1 
1.91 1 3 
Duncan, Rao 
&  Olson 
1.92 1 14 
Janin, Cherfils 
&  Zimmerman 
2.47 unranked 4 
When compared to the X-ray structure, comparing all main-chain atoms. 
bThe predictions were ranked by the individual groups in order of the 
likelihood to correspond to the crystallographic result. 
CUsing the complexes generated by Shoichet &  Kuntz, evaluated with 
a different energy scheme [18]. 
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Figure 2 conformational change. Between the native and com- 
plexed forms of TEM-1, the main-chain root-mean-square 
(rms) deviation was 0.35 A, while for BLIP it was 0.70 A. 
Individual residues in the binding interfaces experienced 
more significant conformational changes. The largest of 
these changes were in the reading-head loops of BLIP 
that make the most intimate contacts with TEM-1. Like 
the specificity loops of many proteinacious inhibitors, 
these loops in the unbound conformation of BLIP had 
high temperature factors, suggesting that they were either 
poorly determined or highly flexible - in either case 
somewhat untrustworthy for docking purposes. 
The overlap of a predicted BLIP-TEM-1 complex with the one solved 
by X-ray crystallography. A main-chain representation of the predicted 
orientation for BLIP is shown in blue, that for the crystallographically 
determined orientation of BLIP is shown in red. The molecular surface 
of TEM-1, from the X-ray structure of the complex, is shown in green. 
The rms between the main-chain atoms of the two complexes is 1.30 A. 
that, for at least some proteins, there is enough informa- 
tion in the positions of the side-chain and main-chain 
atoms that do not undergo conformational change to 
specify the structures of their complexes. 
Was it a fair test? 
This paper represents the first blind test of docking algo- 
rithms, and the skeptical reader might wonder whether 
these results reflect peculiarities of the test system. In 
some ways, the test was an easy one. First, neither of the 
two proteins showed dramatic conformational changes on 
complex formation. Second, BLIP does occlude the active 
site of TEM-1 in the complex, as most of the groups 
expected. This is a reasonable expectation for a 100 pM 
inhibitor [23], but it is not always true. 
In other ways this test case was quite difficult. In contrast 
to most proteins of determined three-dimensional struc- 
ture, little was known about BLIP As it turned out, the 
structure of the complex was unusual. In most complexes 
studied to date, the enzyme presents a concave surface to 
the convex surface of the inhibitor. In the complex 
between BLIP and TEM-1, the interface was mixed; 
BLIP positions loops in the concave active site of TEM-1, 
but the majority of the interface is composed of a convex 
TEM-1 surface matched to a concave inhibitor surface 
(Fig. 2). The two proteins buried 2636 AZ of surface area 
in complex [ 161, an unusually large amount (1200-1700 AZ 
is more common [24]). The complex retained many of the 
traditional sources of uncertainty in protein docking calcu- 
lations. Both proteins showed a small degree of overall 
Room for improvement 
Conformational changes such as those seen in the 
BLIP-TEM-1 complex are examples of degrees of 
freedom present in two interacting macromolecules that 
the current docking algorithms either do not treat, or do 
not treat well. The failure to account for them explains 
many of the errors present in the predicted structures. 
None of the predictions suggested the global aspects of 
conformational change present in the complex, and none 
of the methods predicted even local conformational 
changes successfully [16]. For this reason, many of the 
specific polar contacts seen in the crystal structure are 
missing in the docked structures. Our own top-ranking 
structure (Fig. Z), for instance, includes only three of ten 
hydrogen bonds observed crystallographically between 
BLIP and TEM-1, and includes only one of four ion pairs. 
None of the waters seen crystallographically was predicted 
in the docked complexes. Waters are often involved in 
molecular complexes, but, because they can in principle 
occupy many sites, they are hard to treat computationally 
and their possible specific roles are usually ignored. 
Docking calculations can thus, in favorable circumstances, 
predict protein complexes to ‘low resolution’. The overall 
features of a protein complex can be anticipated, but many 
of the details, the ‘high resolution’ features, will only 
emerge with the experimental structure. What are the 
prospects for improving the ‘resolution’ of the calculations? 
A longstanding difficulty is that of calculating interaction 
energies [6,7]. Predicting the correct polar interactions, for 
instance, is often a matter of distinguishing which of the 
several possible bonding partners will contribute most 
strongly to the interaction energy. Calculating the energy of 
even known polar interactions remains an area of active 
research [25]; our ability to choose reliably among different 
possible interactions must await advances in energy-evalu- 
ation techniques, A second major challenge is that of 
accounting for conformational freedom. Proteins are flexi- 
ble and have many possible conformations, even while 
retaining a particular global fold. Several algorithms now 
exist to explore local flexibility: these range from varying 
the conformations of individual residues [26] to loop-build- 
ing techniques [27] to molecular dynamics or Monte Carlo 
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simulations to genetic algorithms [28]. Some docking algo- 
rithms already include such techniques [9,17,28,29]. While 
potentially helpful, these methods cannot account for 
major hinge motions sometimes seen in molecular asso- 
ciation. To do so efficiently will require fundamental 
advances in our algorithms. 
Structure-based inhibitor discovery 
A second area where molecular docking is used is in struc- 
ture-based inhibitor discovery. We distinguish between 
two applications: discovering new molecules based on the 
structure of a known inhibitor with a receptor, and discov- 
ering novel inhibitors based on the structure of the recep- 
tor alone. In the first area considerable progress has been 
made. Starting with the structures of a ligand-receptor 
complex, several groups have developed potent inhibitors 
that are candidates for clinical trials [30-331. In several 
cases these molecules inhibit their target receptors in the 
low picomolar concentration range, a considerable 
improvement over the starting inhibitors. Computational 
approaches that allow investigators to model the effects of 
derivatization [34] or that identify potential binding sites 
Figure 3 
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Searching molecular databases for novel inhibitors using a docking 
algorithm. A docking program fits molecules from a database of small 
molecule structures into the the receptor binding site. Thousands of fits 
are often calculated for each molecule. Fits are evaluated for 
complementarity, typically by calculating van der Waals and electrostatic 
energies. Promising compounds are bought and tested for their ability to 
bind to the receptor. The structure of the inhibitor-receptor complex can 
then be determined by X-ray crystallography, and this information can be 
used to design new inhibitors. 
Table 2 
Properties of inhibitors discovered using a database search 
and docking approach. 
Receptor Affinity of Affinity of 
lead (~I.M)~ follow-up (PM)~ 
Ref. 
HIV protease 100 5 [44,471 
Thymidylate 5 0.5 [46]; P. Costi, 
synthase unpublished 
Hemagglutinin 500 5 WI 
Cercarial 3 I491 
elastase 
Malarial 
protease 
8 0.1 1491 
CD4-gpl20 5 1 M. McGregor, 
unpublished 
DHFR 7 D. Gschwend, 
unpublished 
aThe initial leads were from DOCK searches of molecular databases. 
Follow-up inhibitors were synthesized on the basis of the initial lead. 
in the receptor [35] have played an important role in these 
efforts [30,36]. Perhaps more important has been the use 
of iterative cycles of synthesis and the determination of 
X-ray crystal structures [33]. Notwithstanding these suc- 
cesses, certain problems persist. Errors in calculated inter- 
action energies limit our ability to predict the effects of 
particular substitutions to inhibitors. Even computation- 
ally intensive thermodynamic cycle methods [37] have 
errors of no less than 1 kcal mol-‘, which translates to a 
five-fold difference in Ki. 
Several groups have developed methods to aid in the dis- 
covery of novel inhibitors based on the structure of the 
receptor alone. One approach has been to use molecular 
fragments to build up new molecules in receptor sites 
[34,38-40]. This approach has lead to the discovery of 
several new inhibitors [38,41]. Another possibility is to 
screen molecular databases for novel inhibitors that can 
complement a receptor of known structure [42-44] (Fig. 
3). This task differs from that of predicting a complex 
between two molecules, although the algorithms used 
may be the same. Rather than asking ‘what is the structure 
of the complex between two molecules known to associ- 
ate?‘, the problem becomes ‘which of the > 100 000 mole- 
cules in the database can be expected to bind tightly to 
the receptor, given the three-dimensional structure of 
each?’ All the problems of the first question are included 
in the second, but the second must also consider whether 
the balance between solvation energies and receptor 
binding favors complex formation, and further must rank 
this balance for each molecule in the database. This would 
seem to be a difficult problem. Nevertheless, Bartlett and 
co-workers have used this approach to discover novel 
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inhibitors for several receptors [42], and we and our col- 
leagues have been able identify novel ligands for seven 
proteins of known structure (Table 2). These ligands bind 
in the pM concentration range and do not resemble the 
previously known inhibitors or substrates for the proteins. 
These successes are explained in part by the smaller size 
of the database molecules when compared to BLIP, which 
considerably simplifies the conformational aspect of the 
docking problem, and also by how the task has been 
framed. The goal is to discover a novel inhibitor, not every 
novel inhibitor in the database; false negatives are accept- 
able. In our experience, these false negatives will usually 
be flexible molecules that exist in the database in a differ- 
ent conformation from the one adopted when they bind to 
the receptor. Control experiments comparing the results 
from a docking calculation and a random screen of data- 
base molecules remain to be performed; these would be 
very desirable, and would give an indication of how many 
possible inhibitors are missed. False positives are tolera- 
ble, and easily screened out, if the screen is restricted to 
commercially available compounds by using a database 
such as the Available Chemicals Directory (supplied by 
MDL Ltd, San Leandro, CA). 
Improving docking algorithms for structure-based 
inhibitor discovery requires advances in several areas. Our 
treatment of ligand and receptor solvation, so important 
for evaluating whether a ligand will bind to a receptor or 
not, are presently crude. As in macromolecular docking, 
better treatments of conformational flexibility and the role 
of specific water molecules and ions will also be impor- 
tant. Predicting where on a receptor surface novel ligands 
might bind needs further consideration. Several recent 
X-ray studies suggest that it may be possible for ligands to 
bind at unexpected sites [45-47]. 
The progress in structure-based inhibitor discovery, and 
the recent success in predicting the structure of a 
protein-protein complex, are reasons for cautious opti- 
mism in molecular docking. Still, it is humbling to recog- 
nize how difficult it has been to fit complementary groups 
together, “like dye and coin”, or like “balls into sockets”. 
Our conceptualization of the problem has not changed 
much since Pauling and Crick first suggested these analo- 
gies, though our ability to numerically simulate biological 
complementarity certainly has. One of the most surprising 
lessons has been that the complementary groups present 
on molecular surfaces may be fitted together in more than 
one way. Because of uncertainties in energy methods, and 
because the existing programs do not yet consider the full 
range of conformational flexibility, docking calculations 
retain many ambiguities. We are not yet at the stage where 
investigators can naively present two structures to a 
docking program and expect to have returned a definitive 
prediction of how they will bind, or if they will bind. What 
docking calculations can do is to present investigators with 
sensible hypotheses that can be experimentally tested. 
Used in this spirit, docking programs will be useful tools 
for investigators interested in understanding the structural 
basis of biological recognition. 
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